Brief: Egetis Q1 Loss Widens To SEK 28.8 Mln
April 26 (Reuters) - Egetis Therapeutics AB (publ)
EGTX.ST :
* Q1 QUARTERLY NET REVENUE MSEK 7.1 (3.8)
* Q1 QUARTERLY LOSS MSEK -28.8 (-19.3)
Source text for Eikon: ID:nMFN1gRrjL
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1